Publication | Closed Access
Nicotinamide metabolism alterations in bladder cancer: Preliminary studies
10
Citations
19
References
2018
Year
Bladder cancer development caused substantial changes in nicotinamide metabolism, such as decreased plasma MetNA and increased Met2PY concentration. Analysis of the nicotinamide and its metabolites concentrations - as new biomarkers - may allow to track the course of pathological processes in cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1